Medi Assist Ser. Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹242 Cr +3.9% YoYSee revenue, profit and what management said. You are viewing Q1 FY26.
MA

Medi Assist Ser.

Q1 FY26Insurance

Medi Assist Healthcare Services Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹191Cr
+13.7% YoY
+1.1% QoQ
Net profit
₹23Cr
+21.1% YoY
+4.5% QoQ
Margin
22%
+1 pp YoY
0 pp QoQ
Price₹361
Market cap₹2.6K Cr
P/E26.4

The short version

Medi Assist generally aims to grow at or faster than the industry growth rate.

From Medi Assist Ser.'s Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Medi Assist generally aims to grow at or faster than the industry growth rate.
  • The acquisition of Paramount Health Services is expected to add meaningful growth from Q2 FY'26 due to its sizable scale and portfolio.
  • Q1 FY'26 saw 19% YoY premium growth, driven by strong new corporate wins (+Rs. 1,000 crores in Q1 alone).
  • Retail premiums growth remains sub-1%, partly due to industry reallocations and a shift toward technology service-based revenues.
  • Technology services revenue (including the Star Health partnership) currently contributes 2.5% and is expected to scale up, offering higher gross margins.
  • Government business and international benefits (Mayfair) segments are growing well and seen as key growth levers.

2 more points from Medi Assist Ser.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

Historically, Medi Assist aims to grow at the industry rate or faster.

Locked: what Medi Assist Ser. said on margins

Also locked on this page: fundraising

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

  • The company is aggressive on growth opportunities across multiple dimensions: TPA business, international (IPMI) business, and technology services as a viable line of business.
  • Investments are focused on expanding technology capabilities and services.
  • Fundraise proceeds are intended for growth-oriented deployment rather than just debt servicing to free up capital for expansion.
  • The Board has approved a preferential allotment to bring in long-term, meaningful shareholders to strengthen the capital structure.
  • Detailed objectives will be communicated in upcoming shareholder notices.
  • The company continues to invest heavily in technology, with current technology spend at 5-7% of revenue.

2 more points from Medi Assist Ser.'s call on capex

Create a free account to keep reading this call

Top-ranked in Insurance

Ranked on what management guided this quarter

Guidance-ranked
1Niva Bupa Health
Rev 2Mar 3
2Max Financial
Rev 3Mar 2
3
Rev 3Mar 3
Sign up free to see 1 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company has taken an in-principle approval from the Board for a fundraising of Rs. 350 crores…

Locked: what Medi Assist Ser. said on fundraising

Also locked on this page: margins

Free account, 30 seconds. No card needed.

Order Book & Pipeline

Relevant insights include: - The company completed the acquisition of Paramount Health Services and Insurance TPA on July 1, 2025, adding a sizable portfolio with annual run-rate revenues of approximately Rs. 140 Crores (IndAS format). - There is an ongoing integration and operational alignment with Paramount over the next 4-5 quarters. - The company has multi-year contracts in its technology services business, operating on a per-claim SaaS-based pricing model.

2 more points from Medi Assist Ser.'s call on order book

Create a free account to keep reading this call

Medi Assist Ser. — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Medi Assist Ser. Q1 FY26 results — key figures

Medi Assist Ser. Q1 FY26 reported results vs Q1 FY25, ₹ crore
₹ CrQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue191168+13.7%189+1.1%
Operating profit (EBITDA)4235+20%41+2.4%
Operating margin22%21%+1 pp22%0 pp
Profit before tax3125+24%30+3.3%
Net profit (PAT)2319+21.1%22+4.5%
EPS (₹)3.182.68+18.7%3.05+4.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹242 Cr, net profit ₹22 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Insurance this season

  • Life Insurance (Q1 FY26)

    Individual non-par business is a key focus area, with growth seen in higher-margin products and increased non-par share to 30.34% of individual APE. Key…

  • Star Health Insu (Q1 FY26)

    2,500 crores profit by FY2028 with a broad split of 20% from underwriting and 80% from investment returns. Key concall takeaways from Star Health & Allied…

  • General Insuranc (Q1 FY26)

    Investment income from interest and dividends runs at approximately INR1,850 crores quarterly, excluding capital gains. Key concall takeaways from General…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Medi Assist Ser. and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Medi Assist Ser. Q1 FY26 results?

Medi Assist generally aims to grow at or faster than the industry growth rate.

What is Medi Assist Ser. share price analysis?

Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹2,605 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medi Assist Ser. planning capital expenditure?

The company is aggressive on growth opportunities across multiple dimensions: TPA business, international (IPMI) business, and technology services as a viable line of business.

Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.